Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 1
2023 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean bonkowski m (180 results)?
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.
Trimarchi H, Gianserra R, Lampo M, Monkowski M, Lodolo J. Trimarchi H, et al. Among authors: monkowski m. Clin Kidney J. 2020 Sep 27;13(5):739-741. doi: 10.1093/ckj/sfaa166. eCollection 2020 Oct. Clin Kidney J. 2020. PMID: 33117528 Free PMC article.
Core Outcome Measure for Life Participation in Patients with Chronic Kidney Disease: Standardized Outcomes in Nephrology Workshops Report.
Hughes A, Gonzalez AM, Amir N, Garcia MA, Caskey FJ, Cerevantes L, Cho Y, Cazzolli R, Dobrijevic E, Elliott MJ, Farragher J, Ferreiro A, Greenwood S, Guha C, Howell M, Huuskes BM, Lampo M, Levin A, Lorca E, Malvar A, Manera K, Mascheroni CA, Mellado H, Molina S, Monkowski M, Silva JR, Sautenet B, Scholes-Robertson N, Sepulveda A, Sluiter A, Sola L, Teixeira-Pinto A, Trimarchi H, van Zwieten A, Ventura JG, Viecelli AK, Wang B, Weng L, Wong G, Wu R, Jaure A; SONG-CKD Life Participation workshop investigators. Hughes A, et al. Among authors: monkowski m. Clin J Am Soc Nephrol. 2025 Jun 26. doi: 10.2215/CJN.0000000724. Online ahead of print. Clin J Am Soc Nephrol. 2025. PMID: 40569671